Long-term outcome of thyroid abnormalities in patients with severe Covid-19

被引:6
|
作者
Muller, Ilaria [1 ,2 ]
Daturi, Anita [2 ]
Varallo, Matteo [2 ]
Re, Tiziana E. [3 ]
Dazzi, Davide [4 ]
Maioli, Sara [2 ]
Crivicich, Erica [2 ]
Di Marco, Francesco [2 ]
Longari, Virgilio [5 ]
Dazzi, Beatrice [1 ]
Castellani, Massimo [5 ]
Mantovani, Giovanna [1 ,2 ]
Arosio, Maura [1 ,2 ]
Salvi, Mario [1 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Endocrinol Unit, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med High Intens Care Unit, Milan, Italy
[4] Casa Cura Val Parma SRL Langhirano Parmigiano Lang, Langhirano, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
关键词
Covid-19; SARS-CoV-2; thyroiditis; thyroid; FUNCTION TESTS; HYPOTHYROIDISM; DEXAMETHASONE;
D O I
10.1530/ETJ-22-0200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time.Methods: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid Tc-99m or I-123 uptake scan.Results: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid Tc-99m/I-123 uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid Tc-99m/I-123 uptake partially recovered from baseline (+28%) but was still reduced in 67% patients.Conclusions: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Long-term outcome of COVID-19 patients with acute kidney injury requiring kidney replacement therapy
    Godi, Ilaria
    Pasin, Laura
    Ballin, Andrea
    Martelli, Gabriele
    Bonanno, Claudio
    Terranova, Francesco
    Tamburini, Enrico
    Simoni, Caterina
    Randon, Ginevra
    Franchetti, Nicola
    Cattarin, Leda
    Nalesso, Federico
    Calo, Lorenzo
    Tiberio, Ivo
    JOURNAL OF ANESTHESIA ANALGESIA AND CRITICAL CARE, 2024, 4 (01):
  • [42] Myopathy in acute and long-term COVID-19
    Tankisi, H.
    Ochala, J.
    CLINICAL NEUROPHYSIOLOGY, 2022, 134 : 141 - 142
  • [43] COVID-19 and Long-Term Economic Growth
    Hao, Jinji
    Gregg, Harry
    Yao, Yao
    AUSTRALIAN ECONOMIC REVIEW, 2023, 56 (02) : 221 - 237
  • [44] Long-term gastrointestinal outcomes of COVID-19
    Xu, Evan
    Xie, Yan
    Al-Aly, Ziyad
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [45] Long-term cardiovascular outcomes of COVID-19
    Yan Xie
    Evan Xu
    Benjamin Bowe
    Ziyad Al-Aly
    Nature Medicine, 2022, 28 : 583 - 590
  • [46] COVID-19: long-term respiratory consequences
    Toufen Junior, Carlos
    Pego-Fernandes, Manuel
    SAO PAULO MEDICAL JOURNAL, 2021, 139 (05): : 421 - 423
  • [47] Long-term Health Consequences of COVID-19
    del Rio, Carlos
    Collins, Lauren F.
    Malani, Preeti
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17): : 1723 - 1724
  • [48] Addressing the Long-term Effects of COVID-19
    Levine, Rachel L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (09): : 823 - 824
  • [49] Long-term cardiovascular outcomes of COVID-19
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (04): : 240 - 240
  • [50] Sequelae of COVID-19 at long-term after
    Pogosova, N., V
    Paleev, F. N.
    Ausheva, A. K.
    Kuchiev, D. T.
    Gaman, S. A.
    Veselova, T. N.
    Belkind, M. B.
    Sokolova, O. Yu
    Zhetisheva, R. A.
    Ternovoy, S. K.
    Boytsov, S. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2022, 18 (02) : 118 - 126